← Back to Search

Medical Illustrations for Healthy Subjects

N/A
Recruiting
Led By Timothy Bickmore, PhD
Research Sponsored by Northeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over 18 years old
Speaks English or Spanish fluently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to figure out how people interpret medical illustrations and what emotions they feel, like anxiety, based on the design of the illustrations.

Who is the study for?
This trial is for adults over 18 who speak English or Spanish fluently, can consent on their own, and have good enough vision (with correction) to read educational health documents. There are no specific exclusion criteria.
What is being tested?
The study aims to evaluate how people interpret medical illustrations and the emotions they experience from different design elements in these images.
What are the potential side effects?
Since this trial involves evaluating medical illustration designs rather than a drug or medical intervention, there are no direct side effects associated with participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I speak English or Spanish fluently.
Select...
I can make my own medical decisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Knowledge
State Anxiety scale from State-Trait Anxiety Inventory
Secondary study objectives
Acceptability
Reading Effort
Satisfaction with the medical illustration

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

20Treatment groups
Experimental Treatment
Group I: Medical Illustration Design Distinction 9, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 9, version B
Group II: Medical Illustration Design Distinction 9, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 9, version A
Group III: Medical Illustration Design Distinction 8, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 8, version B
Group IV: Medical Illustration Design Distinction 8, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 8, version A
Group V: Medical Illustration Design Distinction 7, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 7, version B
Group VI: Medical Illustration Design Distinction 7, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 7, version A
Group VII: Medical Illustration Design Distinction 6, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 6, version B
Group VIII: Medical Illustration Design Distinction 6, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 6, version A
Group IX: Medical Illustration Design Distinction 5, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 5, version B
Group X: Medical Illustration Design Distinction 5, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 5, version A
Group XI: Medical Illustration Design Distinction 4, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 4, version B
Group XII: Medical Illustration Design Distinction 4, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 4, version A
Group XIII: Medical Illustration Design Distinction 3, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 3, version B
Group XIV: Medical Illustration Design Distinction 3, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 3, version A
Group XV: Medical Illustration Design Distinction 2, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 2, version B
Group XVI: Medical Illustration Design Distinction 2, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 2, version A
Group XVII: Medical Illustration Design Distinction 10, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 10, version B
Group XVIII: Medical Illustration Design Distinction 10, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 10, version A
Group XIX: Medical Illustration Design Distinction 1, version BExperimental Treatment1 Intervention
Medical Illustration Design Distinction 1, version B
Group XX: Medical Illustration Design Distinction 1, version AExperimental Treatment1 Intervention
Medical Illustration Design Distinction 1, version A

Find a Location

Who is running the clinical trial?

Tufts Medical CenterOTHER
263 Previous Clinical Trials
256,268 Total Patients Enrolled
Northeastern UniversityLead Sponsor
98 Previous Clinical Trials
62,796 Total Patients Enrolled
Boston UniversityOTHER
470 Previous Clinical Trials
9,954,909 Total Patients Enrolled
~5467 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top